{"id":"NCT03404648","sponsor":"Mayo Clinic","briefTitle":"Staging Prostate Cancer With Hybrid C11-Choline PET/MR and mpMRI","officialTitle":"Staging of Untreated Patients With Very High-risk and High-risk Prostate Carcinoma Utilizing Hybrid C11-choline PET/MR and Pelvic Multiparametric MRI for Personalized Precise Treatment: a Pilot Study","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2017-11-01","primaryCompletion":"2020-01-23","completion":"2020-01-23","firstPosted":"2018-01-19","resultsPosted":"2021-02-08","lastUpdate":"2021-02-08"},"enrollment":19,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"DIAGNOSTIC"},"conditions":["Prostate Adenocarcinoma"],"interventions":[{"type":"DRUG","name":"C-11 choline PET tracer","otherNames":["Choline C-11 Injection"]},{"type":"DRUG","name":"Gadobutrol","otherNames":["Gadavist"]},{"type":"DEVICE","name":"PET/MR scanner","otherNames":["GE SIGNA 3T PET/MR scanner"]}],"arms":[{"label":"High Risk Prostate Cancer Patients","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to find out if a PET/MR scan in combination with standard MRI and CT scans can improve the early detection and treatment of patients with prostate cancer.","primaryOutcome":{"measure":"Uptake Value of C11-choline","timeFrame":"Baseline","effectByArm":[{"arm":"High Risk Prostate Cancer Patients","deltaMin":6.2,"sd":1.8}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"MALE","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":["https://www.mayo.edu/research/clinical-trials"]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":19},"commonTop":[]}}